Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1045266 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-beta-2-Microglobulin (B2M) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant human Beta-2-microglobulin protein
- Description
- Caprylic Acid Ammonium Sulfate Precipitation purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- 4°C
Submitted references Beta2-microglobulin and alpha1-microglobulin as markers of Balkan endemic nephropathy, a worldwide disease.
β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients.
Evaluating percutaneous nephrolithotomy-induced kidney damage by measuring urinary concentrations of β2-microglobulin.
Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.
Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.
Stefanović V, Djukanović L, Cukuranović R, Bukvić D, Ležaić V, Marić I, Ogrizovic SS, Jovanović I, Vlahovic P, Pešić I, Djordjević V
Renal failure 2011;33(2):176-83
Renal failure 2011;33(2):176-83
β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients.
Kals J, Zagura M, Serg M, Kampus P, Zilmer K, Unt E, Lieberg J, Eha J, Peetsalu A, Zilmer M
Scandinavian journal of clinical and laboratory investigation 2011 Jul;71(4):257-63
Scandinavian journal of clinical and laboratory investigation 2011 Jul;71(4):257-63
Evaluating percutaneous nephrolithotomy-induced kidney damage by measuring urinary concentrations of β2-microglobulin.
Sharifiaghdas F, Kashi AH, Eshratkhah R
Urology journal 2011 Fall;8(4):277-82
Urology journal 2011 Fall;8(4):277-82
Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.
Johnston O, Cassidy H, O'Connell S, O'Riordan A, Gallagher W, Maguire PB, Wynne K, Cagney G, Ryan MP, Conlon PJ, McMorrow T
Proteomics. Clinical applications 2011 Aug;5(7-8):422-31
Proteomics. Clinical applications 2011 Aug;5(7-8):422-31
Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.
Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, End P, Staedtler F, Legay F, Carl K, Laurie D, Chibout SD, Vonderscher J, Maurer G
Nature biotechnology 2010 May;28(5):463-9
Nature biotechnology 2010 May;28(5):463-9
No comments: Submit comment
No validations: Submit validation data